company

Instituto de Investigación Marqués de Valdecilla

as of 2026-07-01
Monitor thisAsk about this
at a glance
15 trials sponsored · 9 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

9 assets
AripiprazoleQuetiapineRisperidoneZiprasidoneAntipsychotic treatment discontinuationCognitive batteryPhysical activity programProspective study of fresh samplesRetrospective study of frozen samples

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Aripiprazole
small molecule
drug
Quetiapine
small molecule
drug
Risperidone
small molecule
drug
Ziprasidone
small molecule
drug
Antipsychotic treatment discontinuation
OTHER
drug
Cognitive battery
BEHAVIORAL
drug
Physical activity program
BEHAVIORAL
drug
Prospective study of fresh samples
GENETIC
drug